Pharmacokinetic interactions between herbal remedies and medicinal drugs

References

• AHMAD, N., KATIYAR, S. K. and MUKHTAR, H., 1998, Cancer chemoprevention by tea polyphenols. In C. Ioannides (ed.), Nutrition and Chemical Toxicity (Chichester: Wiley), pp. 301–343.
   Google Scholar
• AMEER, B. and WEINTRAUB, R. A., 1997, Drug interactions with grapefruit juice. Clinical Pharmacokinetics, 33, 103–121.
   PubMed Web of Science ®Google Scholar
• AMES, B. N. and GOLD, L. S., 1998, The prevention of cancer. Drug Metabolism Reviews, 30, 201–223.
   PubMed Web of Science ®Google Scholar
• ANDERSSON, T., MINERS, J. O., VERONESE, M. E. and BIRKETT, D. J., 1994, Diazepam metabolism by human liver microsomes is mediated by both S-mephenytoin hydroxylase and CYP3A isoforms. British Journal of Clinical Pharmacology, 38, 131–137.
   PubMed Web of Science ®Google Scholar
• AYALOGU, E. O., SNELLING, J., LEWIS, D. F. V., TALWAR, S., CLIFFORD, M. N. and IOANNIDES, C., 1995, Induction of hepatic CYP1A2 by the oral administration of caffeine to rats: Lack of association with the Ah locus. Biochimica et Biophysica Acta, 1272, 89–94.
   Google Scholar
• AYRTON, A. D, IOANNIDES, C. and WALKE R., 1988, Induction of rat hepatic cytochrome P-450I proteins by the antimutagen anthraflavic acid. Food and Chemical Toxicology, 26, 909–915.
   PubMed Web of Science ®Google Scholar
• AYRTON, A. D. and MORGAN, P., 2001, Role of transport proteins in drug absorption, distribution and excretion. Xenobiotica, 31, 469–497.
   PubMed Web of Science ®Google Scholar
• AYRTON, A. D., LEWIS, D. F. V., IOANNIDES, C. and WALKER, R., 1987, Anthraflavic acid is a potent and specific inhibitor of cytochrome P-448 activity. Biochi mica et Biophysica Acta, 916, 328–333.
   Google Scholar
• BAEK, N. I., AHN, E. M., Kim, H. Y. and PAUK, Y. D., 2000, Furanocoumarins from the root of Angelica dahurica. Archives of Pharmaceutical Research, 23, 467–470.
   PubMed Web of Science ®Google Scholar
• BAILEY, D. G., ARNOLD, M. O. and SPENCE, J. D., 1998a, Grapefruit juice—drug interactions. British Journal of Clinical Pharmacology, 46, 101–110.
   PubMed Web of Science ®Google Scholar
• BAILEY, D. G., DRESSER, G. K., KREEFT, J. H., MUNOZ, C., FREEMAN, D. J. and BEND, J. R., 2000, Grapefruit—felodipine interaction: effect of unprocessed fruit and probable active ingredients. Clinical Pharmacology and Therapeutics, 68, 468–477.
   PubMed Web of Science ®Google Scholar
• BAILEY, D. G., KREEFT, J. H., MUNOZ, C., FREEMAN, D. J. and BEND, J. R., 1998b, Grapefruit juice—felodipine interaction: effect of naringin and 6',7'-dihydrobergamottin in humans. Clinical Pharmacology and Therapeutics, 64, 248–256.
   PubMed Web of Science ®Google Scholar
• BAILEY, D. G., SPENCE, J. D., MUNOZ, C. and ARNOLD, J. M. O., 1991, Interaction of citrus juices with felodipine and nifedipine. Lancet, 337, 268–269.
   PubMed Web of Science ®Google Scholar
• BALL, S. E., FORRESTER, L. M., WOLF, C. R. and BACKS, D. J., 1990, Differences in the cytochrome P-450 isoenzymes involved in the 2-hydroxylation of oestradiol and 170c-ethinyloestradiol. Biochemistry Journal, 267, 221–226.
   PubMed Web of Science ®Google Scholar
• BARCELO, S., GARDINER, J. M., GESCHER, A. and CHIPMAN, J. K., 1996, CYP2E1 -mediated mechanism of anti-genotoxicity of the broccoli constituent sulforaphane. Carcinogenesis, 17, 277–282.
   PubMed Web of Science ®Google Scholar
• BARNES, J., ANDERSON, L. A. and PHILLIPSON, J. D., 2001, St. John's wort (Hypericum perforatum L): a review of its chemistry, pharmacology and clinical properties. Journal of Pharmacy and Pharmacology, 53, 583–600.
   PubMed Web of Science ®Google Scholar
• BARONE, G. W., CURLEY, B. J., KETEL, B. L. and Aatm-Ezz, S. R., 2001, Herbal supplements: a potential for drug interactions in transplant recipients. Transplantation, 71, 239–241.
   Google Scholar
• BARONE, G. W., CURLEY, B. J., KETEL, B. L., LIGHTFOOT, M. L. and Amm-Ezz, S. R., 2000, Drug interaction between St. John's wort and cyclosporine. Annals of Pharmacotherapy, 34, 1013–1016.
   Google Scholar
• BARONE, J. J. and ROBERTS, H. R., 1996, Caffeine consumption. Food and Chemical Toxicology, 34, 119–129.
   PubMed Web of Science ®Google Scholar
• BERGENDORFF, O., DEKERMEDJIAN, K., NIELSEN, M., SHAN, RD., WITT, R., Ai, J. L. and STERNER, O., 1997, Furanocoumarins with affinity to brain benzodiazepine receptors in vitro. Phytochemistry, 44, 1121–1124.
   PubMed Web of Science ®Google Scholar
• BERNARDI, M., D'INTINO, P. E., TREVISANI, F., CANTELLI-FORTI, G., RAGGI, M. A., TURCHETTO, E. and GASBARRINI, G., 1999, Effects of prolonged ingestion of graded doses of licorice by healthy volunteers. Life Sciences, 55, 863–872.
   Google Scholar
• BERTILSSON, L., TOMSON, T. and TYBRIN G., 1986, Pharmacokinetics: time-dependent changes autoinduction of carbamazepine epoxidation. Journal of Clinical Pharmacology, 26, 459–462.
   PubMed Web of Science ®Google Scholar
• BIBER, A., FISCHER, H., ROMER, A. and CHATTERJEE, S. S., 1998, Oral bioavailability of hyperforin from hypericum extracts in rats and human volunteers. Pharmacopsychiatry, 31, 36–43.
   PubMed Web of Science ®Google Scholar
• BOLT, H. M., 1994, Interactions between clinically used drugs and oral contraceptives. Environmental Health Perspectives, 102, 35–38.
   PubMedGoogle Scholar
• BRADY, J. F., ISHIZAKI, H., FUKUTO, J. M., LIN, M. C., FADEL, A., GAPAC, J. M. and YANG, C. S., 1991b, Inhibition of cytochrome P-450 2E1 by diallyl sulfide and its metabolites. Chemical Research in Toxicology, 4, 642–647.
   PubMed Web of Science ®Google Scholar
• BRADY, J. F., WANG, M.-H., HONG, J.-Y., XIAO, F., Li, Y., Yoo, J.-S., NING, S. M., FUKUTO, J. M., GAPAC, J. M. and YANG, C. S., 1991a, Modulation of rat hepatic microsomal monooxygenase activities and cytotoxicity by diallyl sulfide. Toxicology and Applied Pharmacology, 108, 342–354.
   Google Scholar
• BREIDEBACH, TH., KLIEM, V., BURG, M., RADERMACHER, J. and HOFFMANN, M. W., 2000, Profound drop of cyclosporin A whole blood levels caused by St John's wort (Hypericum perforatum). Transplantation, 69, 2229–2232.
   PubMedGoogle Scholar
• BROCKMDLLER, J., REUM, T., BAUER, S., KERB, R., HUBNER, W. D. and ROOTS, I., 1997, Hypericin and pseudohypericin: pharmacokinetics and effects on photosensitivity in humans. Pharmacopsy-chiatry, 30, 94–101.
   PubMedGoogle Scholar
• BU-ABBAS, A., CLIFFORD, M. N., WALKER, R. and IOANNIDES, C., 1994, Selective induction of rat hepatic CYP1 and CYP4 proteins and of peroxisomal proliferation by green tea. Carcinogenesis, 15, 2575–2579.
   Google Scholar
• BU-ABBAS, A., CLIFFORD, M. N., WALKER, R. and IOANNIDES, C., 1998, Contribution of caffeine and flavanols in the induction of phase II activities by green tea. Food and Chemical Toxicology, 36, 617–621.
   Google Scholar
• BU-ABBAS, A., COPELAND, E., CLIFFORD, M. N., WALKER, R. and IOANNIDES, C., 1999, Cytochrome P450 induction by tea, and its consequences on the bioactivation of chemical carcinogens: contribution of caffeine and flavanols. Environmental Toxicology and Pharmacology, 7, 41–47.
   Google Scholar
• BUDZINSKI, J. W., FOSTER, B. C., VANDENHOEK, S. and ÄRNASON, J. T., 2000, An in vitro evaluation of human cytochrome P450 3A4 inhibition by selected commercial herbal extracts and tinctures. Phytomedicine, 7, 273–282.
   Google Scholar
• BURSTEIN, A. H., HORTON, R. L., DUNN, T., ALFARO, R. M., PISCITELLI, S. C. and THEODORE, W., 2000, Lack of effect of St. John's wort on carbamazepine pharmacokinetics in healthy volunteers. Clinical Pharmacology and Therapeutics, 68, 605–612.
   PubMed Web of Science ®Google Scholar
• CAI, Y., BENNETT, D., NAIR, R. V., CESKA, O., ASHWOOD-SMITH, M. J. and DHOVANNI, J., 1993, Inhibition and inactivation of murine hepatic ethoxy- and pentoxyresorufin O.dealkylase by naturally occurring coumarins. Chemical Research in Toxicology, 6, 872–879.
   Google Scholar
• CANIVENC-LAVIER, M.-C., VERNEVAUT, M.-F., TOTIS, M., SIESS, M.-H., MAGDALOU, J. and SUSCHETET, M., 1996, Comparative effects of flavonoids and model inducers on drug-metabolizing enzymes in rat liver. Toxicology, 114, 19–27.
   PubMed Web of Science ®Google Scholar
• CARSON, S. W., HILL-ZABALA, C. E., ROBERTS, S. H. and HAWKE, R. L., 2000, Inhibitory effect of methanolic solution of St. John's wort (Hypericum perforation) on cytochrome P450 3A4 activity in human liver microsomes. Clinical Pharmacology and Therapeutics, 67, 99.
   Google Scholar
• CASHMAN, J. R., XIONG, Y., LIN, J., VERHAGEN, H., VAN POPPEL, G., VAN BLADEREN, P. J., LARSEN-SU, S. and WILLIAMS, D. E., 1999, In vitro and in vivo inhibition of human flavin-containing monooxygenase form 3 (FM03) in the presence of dietary indoles. Biochemical Pharmacology, 58, 1047–1055.
   Google Scholar
• CHAN, K., Lo, A. C. T., YEUNG, J. H. K. and Woo, K. S., 1995, The effects of danshen (Salvia miltiorrhiza) on warfarin pharmacodynamics and pharmacokinetics of warfarin enantiomers in the rats. Journal of Pharmacy and Pharmacology, 47, 402–406.
   Google Scholar
• CHAN, T. Y. K., 2001, Interaction between warfarin and danshen (Salvia miltiorrhiza). Annals of Pharmacotherapy, 35, 501–504.
   PubMed Web of Science ®Google Scholar
• CHIBA, M., HENSLEIGH, M., NISHIME, J. A., BALANI, S. and LIN, J. J., 1996, Role of cytochrome P450 3A4 in human metabolism of MK-639, a potent human immunodeficiency virus protease inhibitor. Drug Metabolism and Disposition, 24, 307–314.
   PubMed Web of Science ®Google Scholar
• CONSEIL, G., BAUBICHON-CORTAY, H., DAYAN, G., JAULT, J. M., BARRON, D. and DI PIETRO, A., 1998, Flavonoids: a class of modulators with bifunctional interactions at vicinal ATP- and steroid-binding sites on mouse P-glycoprotein. Proceedings of the National Academy of Sciences, USA, 95, 9831–9836.
   Google Scholar
• DE KRUIF, C. A., MARSMAN, J. W., VENEKAMP, J. C., NOORDHOEK, J., BLAAUBOER, B. J. and WORTELBOER, H. M., 1991, Structure elucidation of acid reaction products of indole-3-carbinol: detection in vivo and enzyme induction in vitro. Chemico-Biological Interactions, 80, 303–315.
   PubMedGoogle Scholar
• DE MAAT, M. M. R., HOETELMANS, R. M. W., MATHDT, R. A. A., VAN GORP, E. C. M., MEENHORST, P. L., MULDER, J. W. and BEHNEN, J. H., 2001, Drug interaction between St. John's wort and nevirapine. AIDS, 15, 420–421.
   Google Scholar
• DECKER, C. J., LAITINEN, L. M., BRIDSON, G. W., RAYBUCK, S. A., TUNG, R. D. and CHATUVERDI, P. R., 1998, Metabolism of amprenavir in liver microsomes: role of CYP3A4 inhibition for drug interactions. Journal of Pharmaceutical Sciences, 87, 803–807.
   PubMed Web of Science ®Google Scholar
• DRAGNEV, K. H., Nims, R. W. and LUBET, R. A., 1995, The chemopreventive agent diallyl sulfide. A structurally atypical phenobarbital-type inducer. Biochemical Pharmacology, 50, 2099–2104.
   PubMedGoogle Scholar
• DRAPER, A. J., MADAN, A. and PARKINSON, A., 1997, Inhibition of coumarin 7-hydroxylase activity in human liver microsomes. Archives of Biochemistry and Biophysics, 341, 47–61.
   PubMed Web of Science ®Google Scholar
• DURR, D., STIEGER, B., KULLAK-UBLICK, G. A., RENTSCH, K. M., STEINERT, H. C., MEIER, P. J. and FATTINGER, K., 2000, St. John's wort induces intestinal P-glycoprotein/MDR1 and intestinal and hepatic CYP3A4. Clinical Pharmacology and Therapeutics, 68, 598–604.
   Google Scholar
• EDWARDS, D. J., BELLEVUE In, F. H. and WOSTER, P. M., 1996, Identification of 6',7 dihydroxybergamottin, a cytochrome P450 inhibitor, in grapefruit juice. Drug Metabolism and Disposition, 24, 1287–1290.
   PubMed Web of Science ®Google Scholar
• EDWARDS, D. J., FITZSIMMONS, M. E., SCHUETZ, E. G., YASUDA, K., DUCHARME, M. P., WARBASSE, L. H., WOSTER, P. M., SCHUETZ, J. D. and WATKINS, P., 1999, 6',7'-Dihydroxybergamottin in grapefruit juice and Seville orange juice: effects on cyclosporine disposition, enterocyte CYP3A4, and P-glycoprotein. Clinical Pharmacology and Therapeutics, 65, 237–244.
   PubMed Web of Science ®Google Scholar
• EMEA, 1999, Report from the Ad Hoc Working Group on Herbal Medicinal Products (European Medicine Evaluation Agency).
   Google Scholar
• ERICKSON, D. A., MATHER, G., TRAGER, W. F., LEVY, R. H. and KEIRNS, J. J., 1999, Chacterization of the in vitro biotransformation of the HIV-1 reverse transcriptase inhibitor nevirapine by human hepatic cytochromes P-450. Drug Metabolism and Disposition, 27, 1488–1495.
   PubMed Web of Science ®Google Scholar
• ERNST, E., 1999, Second thoughts about safety of St. John's wort. Lancet, 354, 2014–2016.
   Google Scholar
• ERNST, E., 2000a, Herb-drug interactions: potentially important but woefully under-researched. European Journal of Clinical Pharmacology, 56, 523–534.
   PubMed Web of Science ®Google Scholar
• ERNST, E., 2000b, Possible interactions between synthetic and herbal medicinal products. Part I: Systematic review of indirect evidence. Perfusion, 13, 4–15.
   Web of Science ®Google Scholar
• EVANS, A. M., 2000, Influence of dietary components on the gastrointestinal metabolism and transport of drugs. Therapeutk Drug Monitoring, 22, 131–136.
   PubMed Web of Science ®Google Scholar
• FITZSIMMONS, M. E. and COLLINS, J. M., 1997, Selective biotransformation of the human immunodeficiency virus protease inhibitor sequinavir by human small-intestinal cytochrome P4503A4 — potential contribution to high first-pass metabolism. Drug Metabolism and Disposition, 25, 256–266.
   PubMed Web of Science ®Google Scholar
• FUGH-BERMAN, A., 2000, Herb-drug interactions. Lancet, 355, 134–138.
   PubMed Web of Science ®Google Scholar
• FUHR, U., 1998, Drug interactions with grapefruit juice. Extent, probable mechanism and clinical relevance. Drug Safety, 18, 251–272.
   PubMed Web of Science ®Google Scholar
• FUHR, U., DOEHMER, J., BATTULA, N., WOLFEL, C., KUDLA, C., KEITA, Y. and STAIB, A. H., 1992, Biotransformation of caffeine and theophylline in mammalian cell lines genetically engineered for expression of single cytochrome-P450 isoforms. Biochemical Pharmacology, 43, 225–235.
   PubMed Web of Science ®Google Scholar
• FUKUDA, K., OHTA, T., OSHIMA, Y., OHASHI, N., YOSHIKAWA, M. and YAMAZOE, Y., 1997, Specific CYP3A4 inhibitors in grapefruit juice: furocoumarin dimers as components of drug interaction. Pharmacogenetics, 7, 391–396.
   PubMedGoogle Scholar
• GONZALEZ, F. J., 1996, The CYP2D subfamily. In C. Ioannides (ed.), Cytochromes P450: Metabolic and Toxicological Aspects (Boca Raton: CRC Press), pp. 183–210.
   Google Scholar
• GREESON, J. M., SANFORD, B. and Mown, D. A., 2001, St. John's wort (Hypericum perforatum): a review of the current pharmacological, toxicological, and clinical literature. Psychopharmaco/ogy, 153, 402-41 4.
   Google Scholar
• GUENGERICH, F. P, 1984, Effects of nutritive factors on metabolic processes involving bioactivation and detoxication of chemicals. Annual Reviews in Nutrition, 4, 207–231.
   PubMedGoogle Scholar
• GUENGERICH, F. P, 1988, Oxidation of 17a-ethynyloestradiol by human liver cytochrome P-450. Molecular Pharmacology, 33, 500–508.
   PubMed Web of Science ®Google Scholar
• GUENGERICH, F. P., 1999, Cytochrome P-450 3A4: regulation and role in drug metabolism. Annual Review of Pharmacology and Toxicology, 39, 1–17.
   PubMed Web of Science ®Google Scholar
• GUO, L.-Q., TANIGUCHI, M., CHEN, Q. Y., BABA, K. and YAMAZOE, Y., 2001, Inhibitory potential of herbal medicines on human cytochrome P450-mediated oxidation: properties of umbelliferous or citrus crude drugs and their relative prescriptions. Japanese Journal of Pharmacology, 85, 399–408.
   PubMedGoogle Scholar
• GUO, L.-Q., TANIGUCHI, M., CHEN, Q. Y., Xio, Y.-Q., BABA, K., OHTA, T. and YAMAZOE, Y., 2000, Inhibitory effect of natural furanocoumarins on human microsomal cytochrome P450 3A activity. Japanese Journal of Pharmacology, 82, 122–129.
   PubMedGoogle Scholar
• OUYONNET, D., BELLOIR, C., SUSCETET, M., SIESS, M.-H. and LE BON, A.-M., 2000, Liver subcellular fractions from rats treated by organosulfur compounds from Allium modulate mutagen activation. Mutation Research, 466, 17–26.
   Google Scholar
• OUYONNET, D., SIESS, M.-H., LE BON, A.-M. and SUSCETET, M., 1999, Modulation of phase II enzymes by organosulfur compounds form Allium vegetables in rat tissues. Toxicology and Applied Toxicology, 154, 50–58.
   Google Scholar
• WANG, J. H., 1996, Induction of rat hepatic cytochrome P4501A and P4502B by the methoxsalen. Cancer Letters, 108, 115–120.
   Google Scholar
• HABER, D., SIESS, M.-H., DE WAZIERS, I,. BEAUNE, P. and SUSCHETET, M., 1994, Modification of hepatic drug-metabolizing enzymes in rats fed naturally occurring allyl sulphides. Xenobiotica, 24, 169–182.
   Google Scholar
• HE, K., IYER, K. R., HAYES, R. N., SINZ, M. W., WOOLF, T. F. and HOLLENBERG, P. F., 1998, Inactivation of cytochrome P450 3A4 by bergamottin, a component of grapefruit juice. Chemical Research in Toxicology, 11, 252–259.
   PubMed Web of Science ®Google Scholar
• HECK, A. M., DEWITT, B. A. and LUKES, A. L., 2000, Potential interactions between alternative therapies with warfarin. American Journal of Health-System Pharmacy, 57, 1221–1230.
   PubMed Web of Science ®Google Scholar
• HENDERSON, C. L., HARKEY, M. R., OERSHWIN, M. E., HACKMAN, R. M., STERN, J. S. and STRESSER, D. M., 1999, Effects of ginseng components on c-DNA expressed cytochrome P450 enzyme catalytic activity. Life Sciences, 65, 209–214.
   Web of Science ®Google Scholar
• HOULT, J. R. S. and PAYA, M., 1996, Pharmacological and biochemical actions of simple coumarins: natural products with therapeutic potential. General Pharmacology, 27, 713–722.
   Google Scholar
• HUNTER, J. and HIRST, B. H., 1997, Intestinal secretion of drugs. The role of P-glycoprotein and related drug efflux systems in limiting oral drug absorption. Advanced Drug Delivery Reviews, 25, 129–157.
   Web of Science ®Google Scholar
• IOANNIDES, C. (ed.), 1996, Cytochromes P450: Metabolic and Toxicological Aspects (Boca Raton: CRC Press).
   Google Scholar
• IOANNIDES, C., 1998, Nutritional modulation of cytochromes P450. In C. Ioannides (ed.), Nutrition and Chemical Toxicity (Chichester: Wiley), pp. 115–159.
   Google Scholar
• IOANNIDES, C., 1999, Effect of diet and nutrition on the expression of cytochromes P450. Xenobiotica, 29, 109–154.
   PubMed Web of Science ®Google Scholar
• IOANNIDES, C., 2000, Xenobiotic metabolism and bioactivation by cytochrome P-450. In H. Wiseman, P. Goldfarb, T. Ridgway and A. Wiseman (eds), Biomolecular Free Radical Toxicity: Causes and Prevention (Chichester: Wiley), pp. 103–144.
   Google Scholar
• IOANNIDES, C. ED., 2002, Enzyme Systems that Metabolise Drugs and Other Xenobiotics (Chichester: Wiley).
   Google Scholar
• IOANNIDES, C., DELAFORGE, M. and PARKE, D. V., 1981, Safrole: its metabolism, carcinogenicity and interactions with cytochrome P-450. Food and Cosmetics Toxicology, 19, 657–666.
   PubMedGoogle Scholar
• ISHIHARA, K., KUSHIDA, H., YUZURIHARA, M., WAKUI, Y., YANAGISAWA, T., KAMEI, H., OHMORI, S. and KITADA, M., 2000, Interaction of drugs and Chinese herbs: pharmacokinetic changes of tolbutamide and diazepam caused by extract of Angelica dahurka. Journal of Pharmacy and Pharmacology, 52, 1023–1029.
   PubMed Web of Science ®Google Scholar
• ISITIZAUI, H., BRADY, J. F., NING, S. M. and YANG, C. S., 1990, Effect of phenethyl isothiocyanate on microsomal N-nitrosodimethylamine (NDMA) metabolism and other monooxygenase activities. Xenobiotica, 20, 255–264.
   PubMedGoogle Scholar
• JIN, L. and BAILLIE, T. A., 1997, Metabolism of the chemopreventive agent diallyl sulphide to glutathione conjugates in rats. Chemical Research in Toxicology, 10, 318–327.
   PubMed Web of Science ®Google Scholar
• JOHNE, A., BROCKMDLLER, J., BAUER, S., MAURER, A., LANGHEINRICH, M. and ROOTS, I., 1999a, Interaction of St. John's wort extract with digoxin. European Journal of Clinical Pharmacology, 55, A22.
   Google Scholar
• JOHNE, A., BROCKMDLLER, J., BAUER, S., MAURER, A., LANGHEINRICH, M. and ROOTS, I., 1999b, Pharmacokinetic interaction of digoxin with an herbal extract from St. John's wort (Hypericum perforatum). Clinical Pharmacology and Therapeutics, 66, 338–345.
   PubMed Web of Science ®Google Scholar
• JOSEV, E. S. and TACKETT, R. L., 1999, St John's wort: a new alternative for depression? International Journal of Clinical Pharmacology and Therapeutics, 37, 111–119.
   Google Scholar
• KALL, M. A., VANG, O. and CLAUSEN, J., 1996, Effects of dietary broccoli in human in vivo drug metabolizing enzymes: evaluation of caffeine, oestrone and chlorzoxazone metabolism. Carcinogenesis, 17, 793–799.
   PubMed Web of Science ®Google Scholar
• KAMINSKY, L. C. and ZHANG, Z. Y., 1997, Human P450 metabolism of warfarin. Pharmacology and Therapeutics, 73, 67–74.
   PubMed Web of Science ®Google Scholar
• KANTOLA, T., KivisTO, K. T. and NEUVONEN, P. J., 1998, Grapefruit juice greatly increases serum concentrations of lovastatin and lovastatin acid. Clinical Pharmacology and Therapeutics, 63, 394–402.
   Google Scholar
• KARLIOVA, M., TREICHEL, U., MALAGO, M, FRILLING, A., GERKEN, G. and BROELSCH, C. E., 2000, Interaction of Hypericum perforatum (St. John's wort) with cyclosporin A metabolism in a patient after liver transplantation. Journal of Hepatology, 33, 853–855.
   PubMed Web of Science ®Google Scholar
• KATCHAMART, S., STRESSER, D. M., DEHAL, S. S., KUPFER, D. and WILLIAMS, D. E., 2000, Concurrent flavin-containing monooxygenase down-regulation and cytochrome P-450 induction by dietary indoles in the rat: implications for drug—drug interaction. Drug Metabolism and Disposition, 28, 930–936.
   PubMed Web of Science ®Google Scholar
• KERB, R., BROCKMDLLER, J., STAFFELDT, B., PLOCH, M. and ROOTS, I., 1996, Single-dose and steady-state pharmacokinetics of hypericin and pseudohypericin. Antimicrobial Agents and Chemotherapy, 40, 2087–2093.
   PubMed Web of Science ®Google Scholar
• KERR, B. M., THUMMEL, K. E., WURDEN, C. J., KLEIN, S. M., KROETZ, D. L., GONZALEZ, F. J. and LEVY, R. J., 1994, Human liver carbamazepine metabolism: role of CYP3A4 and CYP2C8 in 10,11-epoxide formation. Biochemical Pharmacology, 47, 1969–1979.
   PubMed Web of Science ®Google Scholar
• KIM, H. J., CHUM, Y. J., PARK, J. D., Kim, S. I., Ron, J. K. and JEONG, T. C., 1997, Protection of rat liver microsomes against carbon tetrachloride-induced lipid peroxidation by red ginseng saponin through cytochrome P450 inhibition. Planta Medica, 63, 41 5–418.
   Google Scholar
• KOENIGS, L. L. and TRAGER, W. F., 1998a, Mechanism-based inactivation of cytochrome P450 2B1 by 8-methoxypsoralen and several other furanocoumarins. Biochemistry, 37, 13184–13193.
   PubMed Web of Science ®Google Scholar
• KOENIGS, L. L. and TRAGER, W. F., 1998b, Mechanism-based inactivation of P450 2A6 by furanocoumarins. Biochemistry, 37, 10047–10061.
   PubMed Web of Science ®Google Scholar
• KRONBACH, T., MATHYS, D., UMENO, M., GONZALEZ, F. J. and MEYER, U. A., 1989, Oxidation of midazolam and triazolarn by human liver cytochrome P4501I1A4. Molecular Pharmacology, 36, 89–96
   PubMed Web of Science ®Google Scholar
• KUDRIAKOVA, T. B., SIROTA, L. A., ROZOVA, G. I. and GORKOV, V. A., 1992, Autoinduction and steady-state pharmacokinetics of carbamazepine and its major metabolites. British Journal of Clinical Pharmacology, 33, 611–615.
   PubMed Web of Science ®Google Scholar
• KUPFERSCHMIDT, H., HA, H., ZIEGLER, W., MEIER, P. and KRAHENBÜHL, S., 1995, Interaction between grapefruit juice and midazolam in humans. Clinical Pharmacology and Therapeutics, 58, 20–28.
   Google Scholar
• KUPFERSCHMIDT, H. H., FATTINGER, K. E., I-IA, H. R., FOLLATH, F. and KRAHENBUHL, S., 1998, Grapefruit juice enhances the bioavailability of the HIV protease inhibitor saquinavir in man. British Journal of Clinical Pharmacology, 45, 355–359.
   Google Scholar
• KWAK, M. K., Kim, S. G., KWAK, J. Y., NOVAK, R. F. and Kim, N. D., 1994, Inhibition of cytochrome P4502E1 expression by organosulfur compounds allylsulfide, allylmercaptan and allyl methylsulfide in rats. Biochemical Pharmacology, 47, 531–539.
   PubMedGoogle Scholar
• LACARELLE, B., RAHMANI, R., DESOUSA, G., DURAND, A., PLACIDI, M. and CANO, J. P.,1991, Metabolism of digoxin, digoxigenin digitoxosides and digoxigenin in human hepatocytes and liver-microsomes. Fundamental and Clinical Pharmacology, 5, 567–582.
   PubMed Web of Science ®Google Scholar
• LAMPE, J. W., KING, I. B., Li, S., GRATE, M. T., BARALE, K. V., CHEN, C., FENG, Z. and POTTER, J. D., 2000, Brassica vegetables increase and apiaceous vegetables decrease cytochrome P450 1A2 in humans: changes in caffeine metabolite ratios in response to controlled vegetable diets. Carcinogenesis, 21, 1157–1162.
   PubMed Web of Science ®Google Scholar
• LESLIE, E. M., MAO, Q., OLESCHUK, C. J., DEELEY, R. G. and COLE, S. P. C., 2001, Modulation of multidrug resistance protein 1 (MRP1/ABCC1) transport and ATPase activities by interaction with dietary flavonoids. Molecular Pharmacology, 59, 1171–1180.
   PubMed Web of Science ®Google Scholar
• LEUNG, Y. K. and Ho, J., 2000, Effects of liquorice on the expression of UGT1A isozymes in rat hepatoma cells. FASEB Journal, 14, abst 1221.
   Google Scholar
• LEWIS, D. F. V., EDDERSHAW, P. J., GOLDFARB, P. J. and TARBIT, M. H., 1996, Molecular modelling of CYP3A4 from an alignment with CYP102: identification of key interactions between putative active site residues and CYP3A-specific chemicals. Xenobiotica, 26, 1067–1086.
   Google Scholar
• LILJA, J. J., KIVISTO, K. T. and NEUVONEN, P. J., 1998, Grapefruit juice—sirnvastatin interaction; effect on serum concentrations of sirnvastatin, simvastatin acid, and HMG-CoA reductase inhibitors. Clinical Pharmacology and Therapeutics, 64, 477–483.
   PubMed Web of Science ®Google Scholar
• LILJA, J. J., KIVISTO, K. T. and NEUVONEN, P. J., 2000b, Duration of effect of grapefruit juice on the pharmacokinetics of the CYP3A4 substrate sirnvastatin. Clinical Pharmacology and Therapeutics, 68, 384–390.
   PubMed Web of Science ®Google Scholar
• LILJA, J. J., KIVISTO, K. T., BACKMAN, J. T. and NEUVONEN, P. J., 2000a, Effect of grapefruit dose on grapefruit juice—triazolam interaction. European Journal of Clinical Pharmacology, 56, 411–415.
   PubMed Web of Science ®Google Scholar
• LIU, E. H., TURNER, L. M., LIN, S. X., KLAUS, L., CHOI, L. Y., WHITWORTH, H., TING, W. and Oz, M. C., 2000, Use of alternative medicine by patients undergoing cardiac surgery. Journal of Thoracic and Cardiovascular Surgery, 120, 335–341.
   PubMedGoogle Scholar
• Lo, A. C. T., CHAN, K., YEUNG, J. H. K. and Woo, K. S., 1992, The effects of Danshen (Salvia miltiorrhiza) on pharmacokinetics and pharmacodynamics of warfarin in rats. European Journal of Drug Metabolism and Pharmacokinetics, 17, 257–262.
   Google Scholar
• LONGO, V., AmATo, G., SALVETTI, A. and GERVASI, P. G., 2000, Heterogeneous effects of anthraquinones on drug-metabolizing enzymes in the liver and small intestine of rat. Chemico-Biological Interactions, 126, 63–77.
   PubMed Web of Science ®Google Scholar
• LOWN, K. S., BAILEY, D. G., FONTANA, R. J., JANARDAN, S. K., ADAIR, C. H., FORTLAGE, L. A., BROWN, M. B., Guo, W. and WATKINS, P. B., 1997, Grapefruit juice increases felodipine oral bioavailability in humans by decreasing intestinal CYP3A protein expression. Journal of Clinical Investigation, 99, 2545–2553.
   PubMed Web of Science ®Google Scholar
• LUNDAHL, J., REGARDH, C. G., EDGAR, B. and JOHNSON, G., 1995, Relationship between the time of intake of grapefruit juice and its effect on pharmacokinetics and pharmacodynamics of felodipine in healthy subjects. European Journal of Clinical Pharmacology, 49, 61–67.
   PubMed Web of Science ®Google Scholar
• MAHEO, K., MOREWL, F., LANGOUET, S., KRAMER, H., LE FERREC, E., KETTERER, B. and GUILLOUZO, A., 1997, Inhibition of cytochromes P-450 and induction of glutathione S-transferases by sulphoraphane in primary human and rat hepatocytes. Cancer Research, 57, 3649–3652.
   PubMed Web of Science ®Google Scholar
• MAI, I., KRUGER, H., BUDDE, K., JOHNE, A., BROCKMOLLER, H., NEUMAYER, H.-H. and ROOTS, I., 2000, Hazardous pharmacokinetic interaction of St John's wort (Hypericum perforatum) with the irnmunosuppressant cyclosporin. International Journal of Clinical Pharmacology and Therapeutics, 38, 500–502.
   Google Scholar
• MALTZMAN, T. H, CitrusTou, M., GOULD, M. N. and JEFCOATE, C. R., 1991, Effects of monoterpenoids on in vivo DMBA—DNA adduct formation and on phase I hepatic metabolizing enzymes. Carcinogenesis, 12, 2081–2087.
   PubMed Web of Science ®Google Scholar
• MARKOWITZ, J. S., DE VANE, C. L., ROULTON, D. W., CARSON, S. W., NAHAS, Z. and RISCH, S. C., 2000, Effect of St. John's wort (Hypericum perforatum) on cytochrome P-450 2D6 and 3A4 activity in healthy volunteers. Life Sciences, 66, PL133—PL139.
   Google Scholar
• MAUREL, P., 1996, The CYP3 family. In C. Ioannides (ed.), Cytochromes P450: Metabolic and Toxicological Aspects (Boca Raton: CRC Press), pp. 241–270.
   Google Scholar
• MAURER, A., JOHNE, A., BAUER, S., BROCKMDLLER, F., DONATH, F., ROOTS, I., LANGHEINRICH, M. and HUBNER, W. D., 1999, Interaction of St. John's wort extract with phenprocoumon. European Journal of Clinical Pharmacology, 55, A22.
   Google Scholar
• MOHRI, K. and UESAWA, Y., 2001, Effects of furanocournarin derivatives in grapefruit juice on nifedipine pharmacokinetics in rats. Pharmaceutical Research, 18, 177–182.
   PubMed Web of Science ®Google Scholar
• MOORE, L. B., GOODWIN, B., JONES, S. A., WISELY, G. B., SERABJIT-SINGH, C. J., WILLSON, T. M., COLLINS, J. L. and KLIEWER, S. A., 2000, St John's wort induces drug metabolism through activation of the pregnane X receptor. Proceedings of the National Academy of Sciences, USA, 97, 7500–7502.
   Google Scholar
• MORI, H. and NISHIKAWA, H., 1998, Naturally occurring organosulphur compounds as potential anticarcinogens. In C. Ioannides (ed.), Nutrition and Chemical Toxicity (Chichester: Wiley), pp. 285–299.
   Google Scholar
• MOM, H., TANAKA, T. and HIRONO, I., 1998, Toxicants in food: naturally occurring. In C. Ioannides (ed.), Nutrition and Chemical Toxicity (Chichester: Wiley), pp. 1–27.
   Google Scholar
• MUNDAY, R. and MUNDSAY, C. M., 1999, Low doses of diallyl sulfide, a compound derived from garlic, increase tissue activities of quinone reductase and glutathione transferaw in the gastrointestinal tract of the rat. Nutrition and Cancer, 34, 42–48.
   PubMed Web of Science ®Google Scholar
• NEBEL, A., SCHNEIDER, B. J., BAKER, R. K. and KROLL, D. J., 1999, Potential metabolic interaction between St. John's wort and theophylline. Annals of Pharmacotherapy, 33, 502.
   PubMed Web of Science ®Google Scholar
• OBACIT, R. S., 2000, Inhibition of cytochrome P450 enzymes by constituents of St John's wort, and herbal preparation used in the treatment of depression. Journal of Pharmacology and Experimental Therapeutics, 294, 88–95.
   PubMedGoogle Scholar
• OBERMEIER, M. T., WHITE, R. E. and YANG, C. S., 1995, Effects of bioflavonoids on hepatic P450 activities. Xenobiotica, 25, 575–584.
   PubMed Web of Science ®Google Scholar
• OLESEN, O. V. and LINNET, K., 1997, Metabolism of the tricyclic antidepressant amitriptyline by cDNA-expressed human cytochrome P450 enzymes. Pharmacology, 55, 235–243.
   PubMed Web of Science ®Google Scholar
• ONO, S., HATANAKA, T., HOTTA, H. SATOH, T., GONZALEZ, F. J. and TSUTSUI, M., 1996, Specificity of substrates and inhibitor probes for cytochrome cytochromes P450: evaluation of in vitro metabolism using cDNA-expressed human P450s and human liver microsomes. Xenobiotica, 26, 681–693.
   Google Scholar
• PANTUCK, E. J., HSIAO, K.-C., LOUB, W. D., WATTENBERG, L. W., KUNTZMAN, R. and CONNEY, A. H., 1976, Stimulatory effects of vegetables on intestinal drug metabolism in the rat. Journal of Pharmacology and Experimental Therapeutics, 198, 278–283.
   Google Scholar
• PANTUCK, E. J., PANTUCK, C. B., ANDERSON, K. E., WATTENBERG, L. W., CONNEY, A. H. and KAPPAS, A., 1984, Effects of brussel sprouts and cabbage on drug conjugation. Clinical Pharmacology and Therapeutics, 35, 161–169.
   PubMed Web of Science ®Google Scholar
• PANTUCK, E. J., PANTUCK, E. B., GARLAND, W. A., MIN, B. H., WATTENBERG, L. W., ANDERSON, K. E., KkPPAS, A. and CONNEY, A. H., 1979, Stimulatory effect of Brussel sprouts and cabbage on human drug metabolism. Clinical Pharmacology and Therapeutics, 25, 88–95.
   PubMed Web of Science ®Google Scholar
• PAOLINI, M., BARILLARI, J., BROCCOLI, M., POZZETTI, L., PEROCCO, P. and CANTELLI-FORTI, G., 1999, Effect of liquorice and glycyrrhizin on rat liver carcinogen metabolising enzymes. Cancer Letters, 145, 35042.
   Google Scholar
• PAOLINI, M., POZZETTI, L., SAPONE, A. and CANTELLI-FORTI, G., 1998, Effect of licorice and glycyrrhizin on murine liver CYP-dependent monooxygenases. Life Sciences, 62, 571–582.
   Google Scholar
• PARKE, D. V. and IOANNIDES, C., 1994, The effects of nutrition on chemical toxicity. Drug Metabolism Reviews, 26, 739–765.
   PubMed Web of Science ®Google Scholar
• PiscrrEw, S. C 14 URSTEIN, A. H., CHAITT, D., ALFARO, R. M. and FALLOON, J., 2000, Indinavir concentrations and St John's wort. Lancet, 355, 547–548.
   Google Scholar
• PREMDAS, P. D., BOWERS, R. J. and FORKERT, P.K., 2000, Inactivation of hepatic CYP2E1 by an epoxide of diallyl sulfone. Journal of Pharmacology and Experimental Therapeutics, 293, 1112–1120.
   PubMed Web of Science ®Google Scholar
• RAMPES, H., SHARPLES, F., MARAGH, S. and FISHER, P., 1997, Introducing complementary medicine into the medical curriculum. Journal of the Royal Society of Medicine, 90, 19–22.
   PubMed Web of Science ®Google Scholar
• RAPEPORT, W. G., MCINNES, G. T., FORREST, G., THOMPSON, C. G., MOORE, M. R., SMITH, D. A. S., GOLDBERG, A., PARK, B. K. and BRODIE, M. J., 1982, Auto- and hetero-induction with carbamazepine in man. British Journal of Clinical Pharmacology, 14, P619–P620.
   Google Scholar
• REICKS, M. M. and CRANKSHAW, D. L., 1996, Modulation of rat hepatic cytochrome P-450 activity by garlic organosulfur compounds. Nutrition and Cancer, 25, 242–248.
   Google Scholar
• ROBY, C. A., ANDERSON, G. D., KANTOR, E., DRYER, D. A. and BURSTEIN, A. H., 2000, St. John's wort: effect on CYP3A4 activity. Clinical Pharmacology and Therapeutics, 67, 451–457.
   PubMed Web of Science ®Google Scholar
• ROOTS, I., JOHNE, A., SCHMIDER, J., BROCKMDLLER, A., MAURER, A., STORMER, E. and DONATH, F., 2000, Interaction from herbal extract from St. John's wort with amitriptyline and its metabolites. Clinical Pharmacology and Therapeutics, 67, PII169.
   Google Scholar
• RUSCHITZKA, F., MEIER, P. J., TURINA, M., LUSCHER, T. F. and NOLL, G., 2000, Acute heart transplant rejection due to St John's wort. Lancet, 355, 548–549.
   PubMed Web of Science ®Google Scholar
• SALPHATI, L. and BENET, Z., 1999, Metabolism of digoxin and digoxigenin digitoxosides in rat liver microsomes: involvement of cytochrome P4503A. Xenobiotica, 29, 171–185.
   PubMed Web of Science ®Google Scholar
• SCHMIEDLIN-REN, P., EDWARDS, D. J., FITZSIMMONS, M. E., HE, K., LOWN, K. S., WOSTER, P. M., RAHMAN, A., THUMMEL, K. E., FISHER, J. M., HOLLENBERG, P. F. and WATKINS, P. B., 1997, Mechanisms of enhanced oral availability of CYP3A4 substrates by grapefruit constituents. Drug Metabolism and Disposition, 25, 1228–1233.
   Google Scholar
• SCHINKEL, A. H., WAENAAR, E., VAN DEEMTER, L., MoL, C. A. A. M. and BORST, P., 1995, Absence of the mdrla P-glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporine A. Journal of Clinical Investigation, 96, 1698–1705.
   Google Scholar
• SHADER, R. I. and GREENBLATT, D. J., 2000, More on oral contraceptives, drug interactions, herbal medicines, and hormone replacement therapy. Journal of Clinical Psychopharmacology, 20, 397–398.
   PubMedGoogle Scholar
• SHON, J. H., PARK, J. Y., KIM, M. S., CHA, I. J., CHUN, B. H. and SHIN, J. G., 2001, Effect of licorice (Radix glycyrrhizae) on the pharmacokinetic (PK) and pharmacodynamics (PD) of midazolam in healthy subjects. Clinical Pharmacology and Therapeutics, 69, P78
   Web of Science ®Google Scholar
• SXOU, K. I. and JAGERSTAD, M., 1998, Toxicants in food: generated during cooking. In C. Ioannides (ed.), Nutrition and Chemical Toxicity (Chichester: Wiley), pp. 59–79.
   Google Scholar
• SOHN, O. S., SURACE, A, FIALA E. S., RICHIE, J. P., JR, COLOSIMO, S., ZANG, E. and WEISBURGER, J. H., 1994, Effects of green and black tea on hepatic xenobiotic metabolizing systems in male F344 rats. Xenobiotica, 24, 119–127.
   Google Scholar
• SOUTHWELL, I. A. and BOURKE, C. A., 2001, Seasonal variation in hypericin content of Hypericum perforatum L. (St John's wort). Phytochemistry, 56, 437–441.
   PubMed Web of Science ®Google Scholar
• STAFFELDT, B., KERB, R., BROCKMDLLER, J., PLOCH, M. and ROOTS, I., 1994, Pharmacokinetics of hypericin and pseudohypericin after oral intake of the hypericum perforaturn extract LI 160 in healthy volunteers. Journal of Geriatric Psychiatry and Neurology, 7, S47–S53.
   Google Scholar
• STEINMETZ, K. A., Kusiti, L. H., BOSTICK, R. M., FoLsom, A. R. and POTTER, J. D., 1994, Vegetables, fruit and colon cancer in the Iowa Women's Health Study. American Journal of Epidemiology, 139, 1–15.
   PubMed Web of Science ®Google Scholar
• STRESSER, D. M., BAILEY, G. S. and WILLIAMS, D. E., 1994, Indole-3-carbinol and O.naphthoflavone induction of aflatoxin B1 metabolism and cytochromes P-450 associated with bioactivation and detoxication of aflatoxin B1 in the rat. Drug Metabolism and Disposition, 22, 383–391.
   PubMed Web of Science ®Google Scholar
• TAKANAGA, H., OHNISHI, A., MURAKAMI, H., MATSUO, H., HIGUCHI, S., URAE, A., ItuE, S., FURUIE, H, MATSUKUMA, K, KIMURA, M., KAWANO, K., O.211, Y., TANAKA, T. and SAWADA, Y., 2000, Relationship between time after intake of grapefruit juice and the effect on pharmacokinetics and pharmacodynamics of nisoldipine in healthy subjects. Clinical Pharmacology and Therapeutics, 67, 201–21 4.
   Google Scholar
• TASSAEENYAKUL, W., Guo, L.-Q., FUKUDA, K., OHTA, T. and YAMAZOE, Y., 2000, Inhibition selectivity of grapefruit components on human cytochromes P450. Archives of Biochemistry and Biophysics, 378, 356–363.
   Google Scholar
• THOMAS, J. A., STARGEL, W. W. and TSCHANZ, C., 1998, Interactions between drugs and diet. In C. Ioannides (ed.), Nutrition and Chemical Toxicity (Chichester: Wiley), pp. 161–182.
   Google Scholar
• THOMAS, K. J., NicHoLL, J. P. and COLEMAN, P., 2001, Use and expenditure on complementary medicine in England; a population based survey. Complementary Therapies in Medicine, 9, 2–11.
   PubMed Web of Science ®Google Scholar
• TRELA, B. A. and CARLSON, G. P., 1987, Effect of flavanone on mixed-function oxidase and conjugation reactions in rats. Xenobiotica, 17, 11–16.
   PubMed Web of Science ®Google Scholar
• VAN TELLINGEN, O., 2001, The importance of drug-transporting P-glycoproteins in toxicology. Toxicology Letters, 120, 31–41.
   PubMedGoogle Scholar
• VANG, O., JENSEN, M. B. and AuTRuP, H., 1990, Induction of cytochrome P4501A1 in rat colon and liver by indole-3-carbinol and 5,6-benzoflavone. Carcinogenesis, 11, 1259–1263.
   PubMed Web of Science ®Google Scholar
• VANG, O., JENSEN, M. B. and AuTRuP, H., 1991, Induction of cytochrome P-450IA1, IA2, IIBI and 11E1 by broccoli in rat liver and colon. Chemico-Biological Interactions, 78, 85–96.
   PubMedGoogle Scholar
• VENKATAKRISHNAN, K., GREENBLATT, D. J., VON MOLTKE, L. L., SCHMIDER, J., HARMATZ, J. S. and SHADER, R. I., 1998, Five distinct human cytochromes mediate amitriptyline N-demethylation in vitro: dominance of CYP2C19 and 3A4. Journal of Clinical Pharmacology, 38, 112–121.
   PubMed Web of Science ®Google Scholar
• VENKATAKRISHNAN, K., VON MOLTKE, L. L. and GREENBLATT, D. J., 1999, Nortriptyline E-10-hydroxylation in vitro is mediated by human CYP2D6 (high affinity) and CYP3A4 (low affinity): implications for interactions with enzyme-inducing drugs. Journal of Clinical Pharmacology, 39, 567–577.
   PubMed Web of Science ®Google Scholar
• VENKATARAMANAN, R., RAMACHANDRAN, V., KOMOROSKI, B. J., ZHANG, S., SCHIFF, P. L. and STROM, S. C., 2000, Milk thistle, a herbal supplement, decreases the activity of CYP3A4 and uridine diphosphoglucuronosyl transferase in human hepatocyte cultures. Drug Metabolism and Disposition, 28, 1270–1273.
   PubMed Web of Science ®Google Scholar
• VISTISEN, K., POULSEN, H. E. and LOFT, S., 1992, Foreign compound metabolism capacity in man measured from metabolites of dietary caffeine. Carcinogenesis, 13, 1561–1568.
   PubMed Web of Science ®Google Scholar
• VON MOLTKE, L. L., GREENBLATT, D. J., HARMATZ, J. S., DUAN, X. S., HARREL, L. M., CONTREAU-BIBBO, M. M., PRICHARD, G. A., WRIGHT, C. E. and SHADER, R. I., 1996, Triazolarn biotransformation by human liver microsomes in vitro: effects of metabolic inhibitors and clinical confirmation of a predicted interaction with ketoconazole. Journal of Pharmacology and Experimental Therapeutics, 276, 370–379.
   Google Scholar
• WANG, J.-S., KENSLER, T. W. and GROOPMAN, J. D., 1998, Toxicants in food: Fungal contaminants. In Nutrition and Chemical Toxicity, edited by C. Ioannides (Chichester: John Wiley & Sons), pp. 29–57.
   Google Scholar
• WARGOVICH, M. J., ImADA, O. and STEPHEN, L. C., 1992, Initiation and post-initiation chemopreventive effects of diallyl sulfide in esophageal carcinogenesis. Cancer Letters, 64, 39–42.
   PubMed Web of Science ®Google Scholar
• WENTWORTH, J. M., AGOSTINI, M., SCHWABE, J. W. and CHATTERJEE, V. K. K., 2000, St John's wort, a herbal antidepressant, activates the steroid X receptor. Journal of Endocrinology, 166, 1211—R16.
   Google Scholar
• WILLS, R. B. H., BONE, K. and MORGAN, M., 2000, Herbal products: active constituents, modes of action and quality control. Nutrition Research Reviews, 13, 47–77.
   Google Scholar
• YANG, C. S., CHHABRA, S. K., HONG, J.-Y. and SMITH, T. J., 2001, Mechanisms of inhibition of chemical toxicity and carcinogenesis by diallyl sulfide (DAS) and related compounds. Journal of Nutrition, 131, 1041S–1045S.
   Google Scholar
• YEE, G. D., STANLEY, D. L., PESSA, L., DALLA COSTA, T., BELTZ, S. E., Ruiz, J. and LOWENTHAL, D. T., 1995, Effect of grapefruit juice on blood cyclosporin concentration. Lancet, 345, 955–956.
   PubMed Web of Science ®Google Scholar
• Yu, C. M., CHAN, J. C. N. and SANDERSON, J. E., 2000, Chinese herbs and warfarin potentiation by `Danshen'. Journal of Internal Medicine, 241, 337–339.
   Google Scholar
• YUE, Q.-Y., BERGQUIST, C. and GERDEN, B., 2000, Safety of St. John's wort (Hypericum perforatum). Lancet, 355, 576–577.
   Google Scholar